Launched Trial Operation of "ICU Bridge" at Jakarta Heart Center

On Monday, July 14, 2025, TXP Medical Co., Ltd. began the trial operation of its intensive care unit (ICU) solution, "ICU Bridge," at the Jakarta Heart Center.

ICU Bridge uses AI-powered Optical Character Recognition (AI-OCR) technology to extract data from medical devices—such as vital sign monitors and ventilators—as well as laboratory test results, to automatically generate ICU charts.
At the Jakarta Heart Center ICU, medical staff currently record patient data manually on handwritten ICU charts, a process that imposes a significant workload. The introduction of ICU Bridge is expected to streamline operations and contribute to broader hospital management improvements.
This trial aims to assess the system’s effectiveness in reducing the workload of medical documentation, and includes surveys of healthcare professionals to gather feedback for future system enhancements and potential full-scale implementation.

About Jakarta Heart Center

Jakarta Heart Center is one of Indonesia's leading private medical institutions specializing in cardiovascular care. It provides advanced cardiac catheterization, heart surgery, and intensive cardiac care services.
With a mission to deliver patient-centered care while maintaining international standards of medical quality, the center actively adopts cutting-edge medical technologies. The ICU Bridge trial is part of this commitment to innovation in healthcare.

TXP Medical will continue to actively promote digital transformation in acute care medical care globally, including in ASEAN countries, with the aim of reducing the workload of medical operations and contributing to improved patient outcomes.